Credit Suisse’s Akero Therapeutics AKRO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | $1.18M | Buy |
|
|||||
|
2023
Q4 | $943K | Sell |
|
|||||
|
2023
Q3 | $2.18M | Sell |
|
|||||
|
2023
Q2 | $2.36M | Buy |
|
|||||
|
2023
Q1 | $1.07M | Buy |
|
|||||
|
2022
Q4 | $1.46M | Buy |
|
|||||
|
2022
Q3 | $441K | Buy |
|
|||||
|
2022
Q2 | $122K | Buy |
|
|||||
|
2022
Q1 | $159K | Buy |
|
|||||
|
2021
Q4 | $229K | Sell |
|
|||||
|
2021
Q3 | $682K | Buy |
|
|||||
|
2021
Q2 | $256K | Sell |
|
|||||
|
2021
Q1 | $326K | Sell |
|
|||||
|
2020
Q4 | $735K | Buy |
|
|||||
|
2020
Q3 | $304K | Buy |
|